In the first case, TAT was fused to a peptide derived from the VHL tumor suppressor gene that inhibits insulin-like growth factor-I receptor (IGF-IR) signaling in renal cell carcinomas (RCC) [33,52,54]. Here, IGF1R is linked to hereditary clear cell renal cell carcinoma.